Investigational Site Number : 2500002

Strasbourg 67098

0 studies enrolling now · 4 studies all time

What they study most

Relapsing Multiple Sclerosis, Sjogren's Syndrome, Sjögren's Syndrome, Squamous Cell Carcinoma of Head and Neck, Systemic Sclerosis

Studies at this site

• Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) — Completed
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) — Stopped early
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis — Completed